how many americans take glp 1 drugs 12% of have used GLP-1 weight loss The GLP-1 Access Gap: Mapping

GLP-1 receptor agonists are also particularly effective for weight loss because they slow down digestion and increase feelings of satiety, decreasing appetite and food intake

For patients, this means navigating a more complex treatment landscape, where outcomes depend not only on the drug itself but on the system surrounding it

The effect of exenatide re-exposure on safety and efficacy

Download our guide to Managing GLP-1 Costs and Supporting Optimal Health Outcomes for ideas on how to start building your own strategy now

Chris Serres: So I think the idea is, at least with the program we wrote about, is it was almost like the, the medications were like training wheels, right

Patients are frequently counselled on injection technique, on managing gastrointestinal side effects, and on the importance of dose titration